Q4 2025 Holdings
Filed 2026-02-20 | 82 holdings | $323.5M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $30.3M | 3,360,937 | 9.4% |
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $28.6M | 2,143,626 | 8.8% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $26.1M | 2,045,070 | 8.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $26.0M | 6,823,690 | 8.0% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $24.3M | 2,350,972 | 7.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $18.6M | 3,466,525 | 5.8% |
| Holley Inc(HLLY) | COM | 43538H103 | $17.1M | 4,146,636 | 5.3% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $10.9M | 7,432,906 | 3.4% |
| Conduent Inc(CNDT) | COM | 206787103 | $9.3M | 4,822,422 | 2.9% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $9.0M | 3,443,659 | 2.8% |
| Civeo Corp(CVEO) | CDA COM NEW | 17878Y207 | $8.5M | 370,530 | 2.6% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $7.4M | 1,243,877 | 2.3% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $7.2M | 392,594 | 2.2% |
| Procore Technologies Inc(PCOR) | COM | 74275K108 | $6.9M | 94,264 | 2.1% |
| Dell Technologies Inc(DELL) | CL C | 24703L202 | $6.8M | 53,848 | 2.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.8M | 360,000 | 1.8% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $5.7M | 327,058 | 1.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $5.7M | 263,249 | 1.8% |
| Imagenebio Inc(IMA) | COM | 45175G207 | $5.7M | 823,785 | 1.8% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $5.2M | 986,240 | 1.6% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $4.9M | 212,638 | 1.5% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $4.4M | 665,000 | 1.4% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $4.2M | 40,259 | 1.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $4.2M | 515,000 | 1.3% |
| Payoneer Global Inc(PAYO) | COM | 70451X104 | $4.0M | 832,810 | 1.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $3.6M | 2,969,199 | 1.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $3.5M | 139,450 | 1.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.4M | 525,000 | 1.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $3.2M | 469,914 | 1.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $2.9M | 733,568 | 0.9% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $2.9M | 1,929,912 | 0.9% |
| NU Hldgs LTD(NU) | ORD SHS CL A | G6683N103 | $2.9M | 173,873 | 0.9% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $2.4M | 150,000 | 0.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $2.4M | 65,944 | 0.7% |
| Niocorp Devs LTD(NIOBW) | *W EXP 03/17/202 | 654484153 | $1.7M | 876,148 | 0.5% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $1.4M | 100,000 | 0.4% |
| Enterprise Prods Partners L(EPD) | COM | 293792107 | $1.0M | 31,290 | 0.3% |
| Fold Hldgs Inc(FLD) | COM CL A | 29103K100 | $985.5K | 856,632 | 0.3% |
| Marker Therapeutics Inc(MRKR) | COM NEW | 57055L206 | $825.8K | 554,250 | 0.3% |
| Chime Finl Inc(CHYM) | COM SHS CL A | 16935C109 | $502.0K | 19,943 | 0.2% |
| Alpha TAU Medical LTD | *W EXP 99/99/999 | M0740A116 | $396.5K | 1,166,118 | 0.1% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $353.0K | 1,718 | 0.1% |
| CID Holdco Inc(DAIC) | COM | 171756109 | $250.8K | 557,361 | 0.1% |
| Omada Health(OMDA) | COM | 68170A108 | $242.6K | 15,377 | 0.1% |
| Servicetitan Inc(TTAN) | SHS CL A | 81764X103 | $241.3K | 2,266 | 0.1% |
| Rezolve AI PLC | *W EXP 08/15/202 | G75398118 | $240.1K | 289,309 | 0.1% |
| Piper Sandler Companies(PIPR) | COM | 724078100 | $206.2K | 607 | 0.1% |
| Syntec Optics Hldgs Inc(OPTXW) | *W EXP 99/99/999 | 87169M113 | $192.8K | 803,132 | 0.1% |
| Alpha Modus Hldgs Inc(AMOD) | CL A | 020952107 | $181.3K | 394,078 | 0.1% |
| Brand Engagement Network Inc(BNAIW) | *W EXP 03/14/202 | 104932116 | $109.1K | 2,726,276 | 0.0% |